RUXIENCE

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: e018c95a43bcd777
Drug Approval Canada Name: RUXIENCE
Product Name: RUXIENCE
Status: Marketed
Status Date: 2020-05-26
Original Market Date: 2020-05-26
Din: 02495724
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Schedule D , Prescription
Ahfs: 10:00.00
Atc Original: L01FA01 RITUXIMAB
Atc Name: l 01 fa 01
Aig Number: 0140241001
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

RITUXIMAB

10 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

e018c95a43bcd777

Type

Standard